HCPCS Level II · Drugs administered other than oral method
J3265Injection, torsemide, 10 mg/ml
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J3265
J3265 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, torsemide, 10 mg/ml.
It was added to HCPCS effective 01/01/1996, and its current record took effect 01/01/1997.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Injection torsemide 10 mg/ml
- Date added
- 01/01/1996
- Action effective
- 01/01/1997
- BETOS
- O1E
Related J32xx codes
- J3230Injection, chlorpromazine hcl, up to 50 mg
- J3240Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3241Injection, teprotumumab-trbw, 10 mg
- J3243Injection, tigecycline, 1 mg
- J3244Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245Injection, tildrakizumab, 1 mg
- J3246Injection, tirofiban hcl, 0.25 mg
- J3247Injection, secukinumab, intravenous, 1 mg
- J3250Injection, trimethobenzamide hcl, up to 200 mg
- J3260Injection, tobramycin sulfate, up to 80 mg
- J3262Injection, tocilizumab, 1 mg
- J3263Injection, toripalimab-tpzi, 1 mg
Common questions about J3265
Is HCPCS J3265 still valid?
- Yes. J3265 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J3265?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.